Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode
NCT02586480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 848
Last updated 2017-10-18
Summary
Observational study on long PR interval using the SafeR mode in bradycardia patients.
Conditions
- Sinus Node Dysfunction
- Atrioventricular Block
Interventions
- DEVICE
-
dual chamber pacemaker with SafeR algorithm
SafeR is an AVB management algorithm: it provides AAI pacing while continuously monitoring AV conduction, it switches to DDD when detecting AVB I, II or III, according to the following criteria: (1) AVB I: 6 long PR intervals, (2) AVB II: 3 blocked atrial events/12 cycles, (3) AVB III: 2 consecutive blocked atrial events. It switches back to AAI mode when needed.
Sponsors & Collaborators
-
LivaNova
lead INDUSTRY
Principal Investigators
-
Jérôme TAIEB, MD · CH du Pays d'Aix - Aix en Provence
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-12-31
Countries
- France
Study Locations
More Related Trials
-
Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
NCT00531037 ·Status: COMPLETED
-
LEft Bundle branchArea Pacing to Avoid Pacing-induced CARdiomyopathy
NCT05910866 ·Status: RECRUITING ·Phase: NA
-
Rate RESPONSIVe Pacing in Patients With Permanent AF Underwent AV Node ABLation and bivEntricular Pacing (RESPONSIBLE)
NCT02354989 ·Status: COMPLETED ·Phase: NA
-
Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)
NCT05541679 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of WATCHMAN Left Atrial Appendage Occlusion Device in Patients With Atrial Fibrillation Versus Rivaroxaban
NCT02549963 ·Status: UNKNOWN ·Phase: PHASE4
-
Pacing the Atrium to Confirm or Exclude Pacemaker Indication in TAVI
NCT05278585 ·Status: RECRUITING
-
Additional Low Voltage Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation
NCT03462628 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
NCT05295628 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
NCT03355456 ·Status: RECRUITING ·Phase: NA
-
Pacemaker Holter Assessment of the Effect of BMS-914392 on Atrial Fibrillation Burden
NCT01356914 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR
NCT07129421 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation
NCT00224341 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
NCT00971204 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Value of Linear Ablation Without Pulmonary Vein Isolation in Persistent Atrial Fibrillation
NCT05468528 ·Status: UNKNOWN ·Phase: NA
-
SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction
NCT00284830 ·Status: COMPLETED ·Phase: NA
-
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852 ·Status: RECRUITING
-
Post-Embolic Rhythm Detection With Implantable Versus External Monitoring
NCT02428140 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Characterization of the Mechanisms of Atrial Fibrillation Maintenance
NCT02497248 ·Status: COMPLETED
-
His-pacing and AV-node Ablation vs. Pulmonary Vein Isolation for Atrial Fibrillation
NCT04512586 ·Status: TERMINATED ·Phase: NA
-
The STandard Versus ImAging SuBstrate Aided Ablation in Severe Left VEntricular Dysfunction VT.
NCT05828667 ·Status: WITHDRAWN ·Phase: NA
-
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
NCT07214376 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Implantable Loop Recorder Versus Conventional Ambulatory Monitoring in Detecting Atrial Fibrillation After Pulmonary Vein Isolation
NCT00697359 ·Status: COMPLETED ·Phase: NA
-
CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
NCT06696170 ·Status: RECRUITING ·Phase: NA
-
Left Atrial Ablation With Permanent Pacemaker or ImplanTable Loop Recorder Follow-UP
NCT01095770 ·Status: UNKNOWN ·Phase: NA
-
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
NCT00589303 ·Status: TERMINATED ·Phase: PHASE3